Health news and discussion on TalkFuse.
It Just Got Harder to Sue Over Glyphosate
A Missouri judge has given final approval to Bayer’s $7.25 billion settlement of lawsuits alleging that its Roundup weedkiller causes cancer. The deal is intended to resolve current and future claims, making it harder for people to sue the company, although it remains subject to appeal.
Bayer inherited about 65,000 lawsuits when it bought Monsanto in 2018, most alleging that glyphosate in Roundup caused cancers including non-Hodgkin’s lymphoma. Individual payments under the settlement may range from $10,000 to $100,000; it follows a $10 billion settlement in 2020 and a recent Supreme Court ruling in Bayer’s favour. The company says the agreement contains no admission of liability or wrongdoing.
In short
- A judge approved Bayer’s $7.25 billion Roundup settlement.
- Payments may range from $10,000 to $100,000 per person.
- The deal aims to resolve future claims, but can be appealed.
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Supporters of the settlement can argue that it offers a practical route to compensation for many claimants while bringing greater certainty after years of costly, drawn-out litigation. Resolving current and future claims could limit legal expenses and uncertainty for Bayer, its employees and customers, while the company’s lack of an admission of wrongdoing preserves its right to contest the allegations.
The case against
Critics can argue that a broad settlement may make it harder for people with serious or future injuries to seek individual redress, especially when payments are limited and the agreement remains subject to appeal. They may also see the deal as weakening public accountability over alleged health risks, particularly given the scale of the claims and the company’s refusal to accept liability.